(a) An issuer may not, based on an
individual's genetic information,
(1) deny or
condition the issuance or effectiveness of a medicare supplement policy or
certificate; or
(2) exclude
benefits under a medicare supplement policy or certificate for a preexisting
condition.
(b) An issuer
may not, based on an individual's genetic information, discriminate in the
pricing of a medicare supplement policy or certificate, including the
adjustment of premium rates.
(c)
Nothing in (a) and (b) of this section limits the ability of an issuer, if
permitted by law, to
(1) based on the
manifestation of a disease or disorder of an insured or applicant
(A) deny or condition the issuance or
effectiveness of a medicare supplement policy or certificate; or
(B) increase of the premium for a group;
or
(2) increase the
premium for a policy based on the manifestation of a disease or disorder of an
individual who is covered under the policy; however, the issuer may not also
use the manifestation of a disease or disorder of one individual as genetic
information about other group members and to further increase the premium for
the group.
(d) Except as
provided in (f) of this section, an issuer may not request or require an
individual or a family member of an individual to undergo a genetic
test.
(e) Nothing in (d) of this
section prohibits an issuer from obtaining and using the results of a genetic
test in making a determination regarding payment consistent with (a) of this
section. An issuer may request only the minimum amount of information necessary
in order to make a determination regarding payment.
(f) An issuer may request, but not require,
that an individual or a family member of an individual undergo a genetic test
if
(1) the request is made according to
research that complies with 45 C.F.R. Part
46 and AS 18.13;
(2) the issuer clearly indicates to each
individual or, in the case of a minor child, the legal guardian of the child to
whom the request is made that
(A) compliance
with the request is voluntary; and
(B) noncompliance will have no effect on
enrollment status or premium or contribution amounts;
(3) genetic information collected or acquired
under this subsection is not used for underwriting, determination of
eligibility to enroll or maintain enrollment status, premium rates, or the
issuance, renewal, or replacement of a policy or certificate;
(4) the issuer notifies the secretary in
writing that the issuer is conducting activities according to the exception
provided under this subsection and includes a description of the activities the
issuer is conducting; and
(5) the
issuer complies with all other federal law applicable to activities conducted
under this subsection.
(g) An issuer may not request, require, or
purchase genetic information for underwriting purposes.
(h) An issuer may not request, require, or
purchase genetic information with respect to an individual before the
individual's enrollment under the policy in connection with the
enrollment.
(i) If an issuer
obtains genetic information incidental to the requesting, requiring, or
purchasing of other information concerning any individual, the request,
requirement, or purchase will not be considered a violation of (h) of this
section if the request, requirement, or purchase is not in violation of (g) of
this section.
(j) In this section,
(1) "issuer," in addition to having the
meaning given in
3
AAC 28.510, includes a third-party administrator or
other person acting for or on behalf of the issuer with respect to a medicare
supplement policy or certificate;
(2) "family member" means, with respect to an
individual, any other individual who is a first-degree, second-degree,
third-degree, or fourth-degree relative of the individual;
(3) "genetic information"
(A) means, with respect to an individual,
information about the individual's genetic tests, the genetic tests of family
members of the individual, and the manifestation of a disease or disorder in
family members of the individual;
(B) includes
(i) with respect to an individual, any
request for or receipt of, genetic services, or participation in clinical
research that includes genetic services, by the individual or any family member
of the individual; and
(ii) with
respect to an individual or family member of an individual who is a pregnant
woman, genetic information of a fetus carried by the pregnant woman, or with
respect to an individual or family member using reproductive technology,
genetic information of any embryo legally held by an individual or family
member;
(C) does not
include information about the sex or age of any individual;
(4) "genetic services" means
(A) a genetic test;
(B) genetic counseling, including obtaining,
interpreting, or assessing genetic information; or
(C) genetic education;
(5) "genetic test" means an analysis of human
deoxyribonucleic acid (DNA), ribonucleic acid (RNA), chromosomes, proteins, or
metabolites that detect genotypes, mutations, or chromosomal changes; "genetic
test" does not include
(A) an analysis of
proteins or metabolites that does not detect genotypes, mutations, or
chromosomal changes; or
(B) an
analysis of proteins or metabolites that is directly related to a manifested
disease, disorder, or pathological condition that could reasonably be detected
by a health care professional with appropriate training and expertise in the
field of medicine involved;
(6) "underwriting purposes" means
(A) rules for, or determination of,
eligibility, including enrollment and continued eligibility, for benefits under
the policy;
(B) the computation of
premium or contribution amounts under the policy;
(C) the application of any preexisting
condition exclusion under the policy; and
(D) other activities related to the creation,
renewal, or replacement of a contract of health insurance or health
benefits.